Cvs Health Quick Ratio (CVS) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cvs Health Corporation  (NYSE: CVS)

Cvs Health's Quick Ratio

CVS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.5 above Cvs Health Corporation average.

Within Pharmacy Services & Retail Drugstore industry 3 other companies have achieved higher Quick Ratio than Cvs Health in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 3698, from total ranking in the second quarter 2026 at 4651.

Explain Quick Ratio?
How much Cash & cash equivalents CVS´s has?
What are CVS´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CVS/financial-strength
https://api.csimarket.com/api/v1/companies/CVS/fundamentals
https://api.csimarket.com/api/v1/companies/CVS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
CVS Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 0.43 %
Y / Y Cash & cash equivalent Change 312.21 %
Quick Ratio MRQ 0.5
CVS's Total Ranking # 3698
Seq. Current Liabilities Change 6.96 %
Seq. Cash & cash equivalent Change 5.38 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 4
Retail Sector # 58
Overall Market # 2643


Quick Ratio Statistics
High Average Low
2.44 0.24 0.05
(Sep 30 2018)   (Jun 30 2016)




Financial Statements
Cvs Health's Current Liabilities $ 93,097 Millions Visit CVS's Balance sheet
Cvs Health's Cash & cash equivalent $ 46,299 Millions Visit CVS's Balance sheet
Source of CVS's Sales Visit CVS's Sales by Geography


Cumulative Cvs Health's Quick Ratio

CVS's Quick Ratio for the trailling 12 Months

CVS Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -1.44 %
Y / Y Cash & cash equivalent TTM Growth 129.62 %
Quick Ratio TTM 0.32
Total Ranking TTM # 3248
Seq. Current Liabilities TTM Growth 0.11 %
Seq. Cash & cash equivalent TTM Growth 45.21 %


On the trailing twelve months basis CVS Cash & cash equivalent more than doubled by 312.21 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Cvs Health's Quick Ratio to 0.32, above CVS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Pharmacy Services & Retail Drugstore industry 12 other companies have achieved higher Quick Ratio than Cvs Health. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending second quarter 2026 at 4117.

Explain Quick Ratio?
How much Cash & cash equivalents CVS´s has?
What are CVS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Pharmacy Services & Retail Drugstore Industry # 13
Retail Sector # 183
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
1.06 0.16 0.06
(Sep 30 2018)   (March 31, 2007)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Pharmacy Services & Retail Drugstore Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Nu Skin Enterprises Inc   0.71 $ 166.639  Millions$ 235.185  Millions
Guardian Pharmacy Services Inc   0.67 $ 119.655  Millions$ 179.089  Millions
Cvs Health Corporation  0.50 $ 46,299.000  Millions$ 93,097.000  Millions
Herbalife Ltd   0.40 $ 409.200  Millions$ 1,031.500  Millions
Petmed Express Inc   0.27 $ 11.418  Millions$ 42.366  Millions
Cardinal Health Inc   0.11 $ 5,264.000  Millions$ 46,404.000  Millions

Date modified: 2026-11-08T19:17:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.